FDA and EMA Discuss Collaboration on Herbal / Botanical Drug Products

To address those gaps, we have started engagement with the botanical community by holding a roundtable with the Reagan-Udall Foundation for the FDA to start the dialogue with key stakeholders to better understand the barriers they see.